The p38 pathway: from biology to cancer therapy
The p38 MAPK pathway is well known for its role in transducing stress signals from the environment. Many key players and regulatory mechanisms of this signaling cascade have been described to some extent. Nevertheless, p38 participates in a broad range of cellular activities, for many of which detai...
| Autores: | , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2020 |
| País: | España |
| Institución: | Universitat Pompeu Fabra |
| Repositorio: | Repositorio Digital de la UPF |
| OAI Identifier: | oai:repositori.upf.edu:10230/44274 |
| Acceso en línea: | http://hdl.handle.net/10230/44274 http://dx.doi.org/10.3390/ijms21061913 |
| Access Level: | acceso abierto |
| Palabra clave: | SAPK Cancer treatment Oncogenicity p38 MAPK Phosphorylation Tumor suppressor |
| id |
ES_e1673fe2f7f2a1689ab5ab1bbcc0de96 |
|---|---|
| oai_identifier_str |
oai:repositori.upf.edu:10230/44274 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
The p38 pathway: from biology to cancer therapyMartínez Limón, AdriánJoaquin i Caudet, ManelCaballero, MaríaPosas Garriga, FrancescNadal Clanchet, Eulàlia deSAPKCancer treatmentOncogenicityp38 MAPKPhosphorylationTumor suppressorThe p38 MAPK pathway is well known for its role in transducing stress signals from the environment. Many key players and regulatory mechanisms of this signaling cascade have been described to some extent. Nevertheless, p38 participates in a broad range of cellular activities, for many of which detailed molecular pictures are still lacking. Originally described as a tumor-suppressor kinase for its inhibitory role in RAS-dependent transformation, p38 can also function as a tumor promoter, as demonstrated by extensive experimental data. This finding has prompted the development of specific inhibitors that have been used in clinical trials to treat several human malignancies, although without much success to date. However, elucidating critical aspects of p38 biology, such as isoform-specific functions or its apparent dual nature during tumorigenesis, might open up new possibilities for therapy with unexpected potential. In this review, we provide an extensive description of the main biological functions of p38 and focus on recent studies that have addressed its role in cancer. Furthermore, we provide an updated overview of therapeutic strategies targeting p38 in cancer and promising alternatives currently being explored.This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (BFU2017-85152-P and FEDER to E.d.N and PGC2018-094136-B-I00 and FEDER to F.P.], the AECC Foundation [PROYE18010POSA to F.P.) and the Catalan Government (2017 SGR 799 to E.d.N and F.P.). F.P. is a recipient of an ICREA Acadèmia award (Catalan Government). We gratefully acknowledge institutional funding from the Spanish Ministry of Economy, Industry and Competitiveness (MINECO) through the Centres of Excellence Severo Ochoa award, from the CERCA Programme of the Catalan Government, and from “Unidad de Excelencia María de Maeztu,” funded by the AEI (CEX2018-000792-M).MDPI202020202020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/44274http://dx.doi.org/10.3390/ijms21061913reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésInt J Mol Sci. 2020; 21(6). pii: E1913info:eu-repo/grantAgreement/ES/2PE/BFU2017-85152-P© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/442742026-06-12T07:21:37Z |
| dc.title.none.fl_str_mv |
The p38 pathway: from biology to cancer therapy |
| title |
The p38 pathway: from biology to cancer therapy |
| spellingShingle |
The p38 pathway: from biology to cancer therapy Martínez Limón, Adrián SAPK Cancer treatment Oncogenicity p38 MAPK Phosphorylation Tumor suppressor |
| title_short |
The p38 pathway: from biology to cancer therapy |
| title_full |
The p38 pathway: from biology to cancer therapy |
| title_fullStr |
The p38 pathway: from biology to cancer therapy |
| title_full_unstemmed |
The p38 pathway: from biology to cancer therapy |
| title_sort |
The p38 pathway: from biology to cancer therapy |
| dc.creator.none.fl_str_mv |
Martínez Limón, Adrián Joaquin i Caudet, Manel Caballero, María Posas Garriga, Francesc Nadal Clanchet, Eulàlia de |
| author |
Martínez Limón, Adrián |
| author_facet |
Martínez Limón, Adrián Joaquin i Caudet, Manel Caballero, María Posas Garriga, Francesc Nadal Clanchet, Eulàlia de |
| author_role |
author |
| author2 |
Joaquin i Caudet, Manel Caballero, María Posas Garriga, Francesc Nadal Clanchet, Eulàlia de |
| author2_role |
author author author author |
| dc.subject.none.fl_str_mv |
SAPK Cancer treatment Oncogenicity p38 MAPK Phosphorylation Tumor suppressor |
| topic |
SAPK Cancer treatment Oncogenicity p38 MAPK Phosphorylation Tumor suppressor |
| description |
The p38 MAPK pathway is well known for its role in transducing stress signals from the environment. Many key players and regulatory mechanisms of this signaling cascade have been described to some extent. Nevertheless, p38 participates in a broad range of cellular activities, for many of which detailed molecular pictures are still lacking. Originally described as a tumor-suppressor kinase for its inhibitory role in RAS-dependent transformation, p38 can also function as a tumor promoter, as demonstrated by extensive experimental data. This finding has prompted the development of specific inhibitors that have been used in clinical trials to treat several human malignancies, although without much success to date. However, elucidating critical aspects of p38 biology, such as isoform-specific functions or its apparent dual nature during tumorigenesis, might open up new possibilities for therapy with unexpected potential. In this review, we provide an extensive description of the main biological functions of p38 and focus on recent studies that have addressed its role in cancer. Furthermore, we provide an updated overview of therapeutic strategies targeting p38 in cancer and promising alternatives currently being explored. |
| publishDate |
2020 |
| dc.date.none.fl_str_mv |
2020 2020 2020 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10230/44274 http://dx.doi.org/10.3390/ijms21061913 |
| url |
http://hdl.handle.net/10230/44274 http://dx.doi.org/10.3390/ijms21061913 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
Int J Mol Sci. 2020; 21(6). pii: E1913 info:eu-repo/grantAgreement/ES/2PE/BFU2017-85152-P |
| dc.rights.none.fl_str_mv |
http://creativecommons.org/licenses/by/4.0/ info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0/ |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
MDPI |
| publisher.none.fl_str_mv |
MDPI |
| dc.source.none.fl_str_mv |
reponame:Repositorio Digital de la UPF instname:Universitat Pompeu Fabra |
| instname_str |
Universitat Pompeu Fabra |
| reponame_str |
Repositorio Digital de la UPF |
| collection |
Repositorio Digital de la UPF |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869422289692393472 |
| score |
15.812429 |